Home > Rheumatology > Community Rheumatology Clinics: Pegloticase safe and effective with any immunomodulator

Community Rheumatology Clinics: Pegloticase safe and effective with any immunomodulator

Expert
Dr Aaron Broadwell, Shreveport, Louisiana
Conference
ACR 2021
Pegloticase is effective for lowering serum urate patients with uncontrolled or refractory gout, although more than half of patients experience anti-drug antibody development which limits its efficacy [1]. Administering pegloticase in conjunction with an immunomodulating therapy has been shown to improve sustained urate reduction while on treatment [2]. Very little data is available pertaining to who might be the best candidate for this approach, as well as which immunomodulation agent should be used. The data presented by Dr Broadwell reflected the experience from 2 community rheumatology practices where immunomodulating therapy is routinely prescribed in patients undergoing pegloticase treatment. Rheumatologist Dr Aaron Broadwell (Shreveport, Louisiana) presented the results of the study during the annual American College of Rheumatology Convergence of 2021, which was held from 3...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on